Literature DB >> 9873227

Cellular immune response to retinal S-antigen and interphotoreceptor retinoid-binding protein fragments in Eales' disease patients.

S Saxena1, J Rajasingh, S Biswas, D Kumar, T Shinohara, V K Singh.   

Abstract

The role of retinal antigens in Eales' disease was studied in 24 patients and an equal number of healthy controls. Lymphocyte proliferative responses were tested in vitro against native S-antigen, its uveitopathogenic peptides (peptide M and peptide G), yeast histone H3 peptide and uveitopathogenic fragment of interphotoreceptor retinoid-binding protein (IRBP; R16) to establish their role in the pathogenesis of Eales' disease. Out of 24 Eales' disease patients, 6 showed significant proliferative response against S-antigen, its uveitogenic fragments or IRBP. None among the controls showed any response to any retinal antigen used in this study. There was no statistically significant difference in the response to purified protein derivative between patients and controls. These results suggest that retinal antigens may play a role in the etiopathogenesis of Eales' disease. An extraneous agent that could result in exposure of normally sequestered uveitopathogenic antigens of the immune system, leading to an exuberant immune response in the eye may initiate the disease.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 9873227     DOI: 10.1159/000028049

Source DB:  PubMed          Journal:  Pathobiology        ISSN: 1015-2008            Impact factor:   4.342


  8 in total

Review 1.  Immunomodulation of autoimmune responses with monoclonal antibodies and immunoadhesins: treatment of ocular inflammatory disease in the next millennium.

Authors:  A D Dick; J D Isaacs
Journal:  Br J Ophthalmol       Date:  1999-11       Impact factor: 4.638

2.  Protein-ligand interaction studies of retinol-binding protein 3 with herbal molecules using AutoDock for the management of Eales' disease.

Authors:  Anshul Tiwari; Sandeep Saxena; A B Pant; Prachi Srivastava
Journal:  J Ocul Biol Dis Infor       Date:  2012-12-30

3.  Comparative modeling of retinol-binding protein-3 and retinal S-antigen in Eales' disease and prediction of their binding sites using computational methods.

Authors:  Anshul Tiwari; Ashish Chandra Trivedi; Prachi Srivastava; Aditya Bhusan Pant; Sandeep Saxena
Journal:  J Ocul Biol Dis Infor       Date:  2011-07-26

4.  Tumor necrosis factor-α-mediated severity of idiopathic retinal periphlebitis in young adults (Eales' disease): implication for anti-TNF-α therapy.

Authors:  Sandeep Saxena; Aditya B Pant; Vinay K Khanna; Kamlesh Singh; Rajendra K Shukla; Carsten H Meyer; Vijay K Singh
Journal:  J Ocul Biol Dis Infor       Date:  2010-07-16

5.  Treatment of neuro-ophthalmologic manifestations of tuberculosis.

Authors:  Susannah Mistr; Pamela S Chavis
Journal:  Curr Treat Options Neurol       Date:  2006-01       Impact factor: 3.972

6.  Eales' disease: epidemiology, diagnostic and therapeutic concepts.

Authors:  Sergio Murillo López; Silvia Medina Medina; Fernando Murillo López
Journal:  Int J Retina Vitreous       Date:  2022-01-04

7.  A compound heterozygous mutation in the S-Antigen Visual Arrestin SAG gene in a Chinese patient with Oguchi type one: a case report.

Authors:  Zhen Deng; Fangli Fan; Danyan Tang; Yifeng Wu; Yujie Shu; Kunlin Wu
Journal:  BMC Ophthalmol       Date:  2022-03-04       Impact factor: 2.209

8.  Spectral domain optical coherence tomography evaluation of macular changes in Eales disease.

Authors:  Neha Goel; Vinod Kumar; Supriya Arora; Pooja Jain; Basudeb Ghosh
Journal:  Indian J Ophthalmol       Date:  2018-03       Impact factor: 1.848

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.